Robert E. W. Hancock

Last updated

Ventures

Hancock co-founded the following companies:

References

  1. 1 2 3 4 "Scientific Advisory Board". Qu Biologics Inc. 2018-05-07. Archived from the original on 2023-05-07. Retrieved 2023-05-07.
  2. Hancock, Robert Ernest William (1974). Cross resistance amongst coliphages (PhD thesis). University of Adelaide. Retrieved 2021-07-25.
  3. Hancock, R.E.W. (2001). "Cationic peptides: effectors in innate immunity and novel antimicrobials". The Lancet Infectious Diseases. 1 (3): 156–164. doi:10.1016/S1473-3099(01)00092-5. PMID   11871492.
  4. Stover KC, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P, Hickey MJ, Brinkman FSL, Hufnagle WO, Kowalik DJ, Lagrou M, Garber RL, Goltry L, Tolentino E, Westbrock-Wadman S, Yuan Y, Brody LL, Coulter SN, Folger KR, Kas A, Lim R, Smith K, Spencer D, Wong GK-S, Wu Z, Paulsen I, Reizer J, Saier MH, Hancock REW, Lory S, Olson MV (2000). "Complete genome sequence of Pseudomonas aeruginosa: an opportunistic pathogen". Nature. 406 (6799): 956–964. doi: 10.1038/35023079 . PMID   10984043.
  5. 1 2 Fjell CD, Hiss JA, Hancock REW, Schneider G (2012). "Designing antimicrobial peptides: Form follows function". Nature Reviews Drug Discovery. 11 (1): 37–51. doi: 10.1038/nrd3591 . PMID   22173434. S2CID   24213234.
  6. Hilpert K, Volkmer-Engert R, Walter T, Hancock REW (August 2005). "High-throughput generation of small antibacterial peptides with improved activity". Nature Biotechnology. 23 (8): 1008–12. doi:10.1038/nbt1113. PMID   16041366. S2CID   25692464.
  7. 1 2 Scott MG, Dullaghan E, Mookherjee N, Glavas N, Waldbrook M, Thompson A, Wang A, Lee K, Doria S, Hamill P, Yu JJ, Li Y, Donini O, Guarna MM, Finlay BB, North JR, Hancock REW (March 2007). "An anti-infective peptide that selectively modulates the innate immune response". Nature Biotechnology. 25 (4): 465–472. doi:10.1038/nbt1288. PMID   17384586. S2CID   6127218.
  8. Hancock REW, Haney EF, Gill EE (2016). "The immunology of host defence peptides: Beyond antimicrobial activity". Nat Rev Immunol. 16 (5): 321–334. doi:10.1038/nri.2016.29. PMID   27087664. S2CID   12975620.
  9. Yeung ATY, Hale C, Lee AH, Gill EE, Bushell W, Parry-Smith D, Goulding D, Pickard D, Roumeliotis T, Choudhary J, Thomson N, Skarnes WC, Dougan G, Hancock REW (2017). "Exploiting induced pluripotent stem cell-derived macrophages to unravel key host factors influencing Chlamydia trachomatis pathogenesis". Nature Communications. 8 15013. Bibcode:2017NatCo...815013Y. doi:10.1038/ncomms15013. PMC   5414054 . PMID   28440293.
  10. "Prix Galien Canada 2012 Research" . Retrieved 19 April 2018.
  11. "Find a Recipient". The Governor General of Canada. Retrieved 19 April 2018.
  12. "CAHS Fellows". Canadian Academy of Health Sciences. Retrieved 19 April 2018.
  13. "2009 Recipient". Order of British Columbia. Retrieved 19 April 2018.
  14. "Inimex Co-Founder Bob Hancock Receives 2006 Michael Smith Prize". T-Net. Retrieved 19 April 2018.
  15. "Past Award Winners". Royal Society of Canada. Retrieved 19 April 2018.
  16. "Antimicrobial Research Award (Formerly Cubist-ICAAC Award)". American Society for Microbiology. Retrieved 19 April 2018.
  17. "Find a Recipient". The Governor General of Canada. Retrieved 19 April 2018.
  18. "Canada Research Chairs". Government of Canada. 29 November 2012. Retrieved 19 April 2018.
  19. "Fellows". Royal Society of Canada. Retrieved 20 April 2018.
  20. Lindsay, Bethany (September 27, 2016). "UBC professor working on new tool to fight painful, dangerous infections". Vancouver Sun. Retrieved 20 April 2018.
  21. "Inimex Raises US $22 Million in the Fight Against Antibiotic Resistance". Newswire. Retrieved 20 April 2018.
Robert E. W. Hancock
UBC T2C5431.jpg
Hancock in 2016
Born (1949-03-23) March 23, 1949 (age 76)
Nationality Canadian
OccupationProfessor
AwardsOfficer of the Order of Canada, ICAAC Antimicrobial Research Award, Prix Galien, Order of British Columbia
Academic background
Alma mater University of Adelaide